Vanberra Signal

CureMatch

Curated by Signal

Matches cancer patients with optimal Rx combinations

Overview

CureMatch is an oncology precision medicine startup that offers a computational decision support platform. The platform uses genomic, proteomic and/ or epigenetic data, obtained from any CLIA-approved lab source. Their proprietary algorithms then analyze the data and match each patient with approved and investigational durgs, while assessing drug-drug interactions, toxicity and pharmacogenomics. The final report suggests optimum combination therapies that are best suited for the patient.

Key facts

Founded
2015

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Expert-led fitness coaching solutions

    Health TechnologyDes Moines, United States
  • Online platform for tracking feelings and emotions

    Health TechnologyManhattan, United States
  • Provider of a telemedicine platform for cannabis medicines recommendation

    Health TechnologyPlymouth, United States

About CureMatch

What does CureMatch do?

CureMatch is an oncology precision medicine startup that offers a computational decision support platform.

Where is CureMatch headquartered?

CureMatch is headquartered in San Diego, United States.

When was CureMatch founded?

CureMatch was founded in 2015.

Which sector is CureMatch in?

CureMatch operates in Health Technology.

Who are CureMatch's competitors?

Companies similar to CureMatch include Body Project Iowa, B-posi+ive, and Creating Well Being.